Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merrimack lung cancer drug fails goal in one mid-stage trial group
Merrimack lung cancer drug fails goal in one mid-stage trial group
Merrimack lung cancer drug fails goal in one mid-stage trial group
Submitted by
admin
on April 4, 2013 - 9:22am
Source:
Reuters
News Tags:
lung cancer
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
Headline:
Merrimack lung cancer drug fails goal in one mid-stage trial group
Do Not Allow Advertisers to Use My Personal information
